NDC 87717-502 – Docusate Sodium and Sennosides
Docusate Sodium 50 mg/1; Sennosides 8.6 mg/1 · Tablet · Oral
Product NDC87717-502
Product details
- Brand name
- Docusate Sodium and Sennosides
- Generic name
- Docusate Sodium and Sennosides
- Labeler
- Morepen Bio Inc
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- OTC MONOGRAPH DRUG · M007
- Marketed since
- July 10, 2026
- Listing expires
- December 31, 2027
Active ingredients
- Docusate Sodium 50 mg/1
- Sennosides 8.6 mg/1
Uses, dosage, side effects and warnings for Docusate Sodium and Sennosides →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 87717-502-01 | 1000 TABLET in 1 BOTTLE, PLASTIC (87717-502-01) | Jul 10, 2026 |
| 87717-502-02 | 100 TABLET in 1 BOTTLE, PLASTIC (87717-502-02) | Aug 14, 2026 |
Other Docusate Sodium and Sennosides products
- 62993-0002 Docusate Sodium 50 mg/1; Sennosides 8.6 mg/1 · Tablet · Morepen Laboratories Limited
- 35916-0453 Sennosides 8.6 mg/1; Docusate Sodium 50 mg/1 · Capsule, Gelatin Coated · SOFTGEL HEALTHCARE PRIVATE LIMITED
- 35916-0454 Sennosides 8.6 mg/1; Docusate Sodium 50 mg/1 · Capsule, Gelatin Coated · SOFTGEL HEALTHCARE PRIVATE LIMITED
- 35916-0477 Docusate Sodium 50 mg/1; Sennosides 8.6 mg/1 · Capsule, Liquid Filled · SOFTGEL HEALTHCARE PRIVATE LIMITED